Glutathione oxidation in cerebrospinal fluid as a biomarker of oxidative stress in amyotrophic lateral sclerosis

Glutathione oxidation in cerebrospinal fluid as a biomarker of oxidative stress in amyotrophic lateral sclerosis

Saved in:

Bibliographic Details
Main Authors:	Trong Khoa Pham, Nick Verber, Martin R. Turner, Andrea Malaspina, Mark Oliver Collins, Richard J. Mead, Pamela J. Shaw
Format:	Article
Language:	English
Published:	BMC 2025-07-01
Series:	Translational Neurodegeneration
Online Access:	https://doi.org/10.1186/s40035-025-00496-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Urinary P75: a promising biomarker for amyotrophic lateral sclerosis
by: Martin R Turner, et al.
Published: (2025-08-01)

Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients
by: Chiara Lucchi, et al.
Published: (2024-08-01)

Cerebrospinal fluid from patients with amyotrophic lateral sclerosis inhibits sonic hedgehog function.
by: Anna Drannik, et al.
Published: (2017-01-01)

Management of Dysarthria in Amyotrophic Lateral Sclerosis
by: Elena Pasqualucci, et al.
Published: (2025-07-01)

Early detection of motor dysfunction in the SOD1G93A mouse model of Amyotrophic Lateral Sclerosis (ALS) using home cage running wheels.
by: Ellen J Bennett, et al.
Published: (2014-01-01)

The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis
by: Alexander Bampton, et al.
Published: (2024-11-01)

Glial Cells in Amyotrophic Lateral Sclerosis
by: Jurate Lasiene, et al.
Published: (2011-01-01)

Genetics of familial amyotrophic lateral sclerosis
by: A. V. Savinova, et al.
Published: (2021-10-01)

Deontological aspects of the amyotrophic lateral sclerosis
by: T. M. Alekseeva, et al.
Published: (2018-01-01)

Opinion: Conjugal amyotrophic lateral sclerosis
by: Roberto E. Sica, et al.
Published: (2010-04-01)

Pain in Amyotrophic Lateral Sclerosis Is Underrated
by: Soyoung Kwak, et al.
Published: (2024-12-01)

Comparison of blood RNA extraction methods used for gene expression profiling in amyotrophic lateral sclerosis.
by: Nadhim Bayatti, et al.
Published: (2014-01-01)

An Objective Functional Characterisation of Head Movement Impairment in Individuals with Neck Muscle Weakness Due to Amyotrophic Lateral Sclerosis.
by: Silvia Pancani, et al.
Published: (2017-01-01)

sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden
by: Lin Jiao, et al.
Published: (2024-12-01)

Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis
by: Adam N. Trautwig, et al.
Published: (2025-05-01)

Network spreading and local biological vulnerability in amyotrophic lateral sclerosis
by: Asa Farahani, et al.
Published: (2025-08-01)

Optimised and rapid pre-clinical screening in the SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).
by: Richard J Mead, et al.
Published: (2011-01-01)

Voxel-based morphometry in amyotrophic lateral sclerosis
by: I. S. Bakulin, et al.
Published: (2019-01-01)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
by: Wolfgang Becker, et al.
Published: (2019-09-01)

Epidemiology of amyotrophic lateral sclerosis in the Krasnoyarsk region
by: E. A. Ermilov, et al.
Published: (2024-01-01)

Presymptomatic genetic counseling in amyotrophic lateral sclerosis
by: Yu. A. Shpilyukova, et al.
Published: (2018-01-01)

Clinical features of fatigue in amyotrophic lateral sclerosis
by: E. V. Pervushina, et al.
Published: (2025-04-01)

Advances in Mouse Models of Amyotrophic Lateral Sclerosis
by: LUO Lianlian, et al.
Published: (2025-06-01)

Autoimmunity in Amyotrophic Lateral Sclerosis: Past and Present
by: Mario Rafael Pagani, et al.
Published: (2011-01-01)

Amyotrophic Lateral Sclerosis and Novel Therapeutic Strategies
by: Brett Morrison, et al.
Published: (2012-01-01)

An Advancements In Treatment Of Amyotrophic Lateral Sclerosis (ALS)
by: Weronika Ożóg, et al.
Published: (2025-06-01)

The Role of mTOR in Amyotrophic Lateral Sclerosis
by: José Augusto Nogueira-Machado, et al.
Published: (2025-04-01)

Major advances in amyotrophic lateral sclerosis in 2020
by: Divyani Garg, et al.
Published: (2021-01-01)

Dynamics of Onset and Progression in Amyotrophic Lateral Sclerosis
by: Michael Swash, et al.
Published: (2025-06-01)

Quality of life of patients with Amyotrophic Lateral Sclerosis
by: Sue Christine Siqueira, et al.
Published: (2017-06-01)

Quality of life of patients with Amyotrophic Lateral Sclerosis
by: Sue Christine Siqueira, et al.
Published: (2017-06-01)

Twitch force in human Amyotrophic Lateral Sclerosis
by: Laura Libonati, et al.
Published: (2025-05-01)

Fatigue in amyotrophic lateral sclerosis and correlated factors
by: Mariana Asmar Alencar, et al.
Published: (2022-10-01)

Amyotrophic lateral sclerosis in a tricenarian female
by: Anshul Sood, MBBS, et al.
Published: (2025-02-01)

Staging model for amyotrophic lateral sclerosis in Singapore
by: Yuan Teck Tay, et al.
Published: (2022-07-01)

A Successful Pregnancy with Amyotrophic Lateral Sclerosis
by: P. D. M. Pathiraja, et al.
Published: (2020-01-01)

Magnetic Resonance Imaging in Amyotrophic Lateral Sclerosis
by: Katja Kollewe, et al.
Published: (2012-01-01)

Amyotrophic lateral sclerosis: considerations on diagnostic criteria
by: Marco A. Chieia, et al.
Published: (2010-12-01)

Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01)

Therapeutic and diagnostic potential of extracellular vesicles in amyotrophic lateral sclerosis
by: Taylor J. Ellison, et al.
Published: (2023-12-01)